Development of an automated high-content immuno-fluorescence assay of pSmads quantification: proof-of-concept with drugs inhibiting the BMP/TGFbeta pathways
V. KHODR, L. CLAUZIER, P. MACHILLOT, A. SALES, E. MIGLIORINI, C. PICART
The paper develops an automated high-content immunofluorescence assay for pSmad quantification and demonstrates its use in drug testing on biomimetic films.
bioRxiv · Dec 14, 2023 · PreprintBioengineering